# Trade Mark Journal No.2025/032 8 August 2025

## WO0000001866449 (42)

Office of origin: United States of America

Date of International Registration:16 June 2025
Date of designation in the UK: 16 June 2025

Class 42
  Scientific and technological research in the field of eye diseases and conditions; design and development of pharmaceuticals preparations, inserts, implants and technology in the field of ophthalmology.

EyePoint Pharmaceuticals US, Inc.

Representative: David Davis Baker & McKenzie LLP, 300 East Randolph Street, Suite 5000, Chicago IL 60601, UNITED STATES OF AMERICA